1-3 of 3
Thomas Pohl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 920: Harnessing multiple mechanisms of action to target Nectin-4 as anti-tumor therapeutics

Yi Pei, Thomas Pohl, Ahmed Hassan, Anna Przybyla, Raymond Yu, Huarui Lu, Fangqiang Tang, Kevin Chen, Wei Jin, Krizia Dominguez, Haichun Huang, Ming Lei, Zhong Liu, Han Li
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 920.
https://doi.org/10.1158/1538-7445.AM2021-920
Published: 01 July 2021
View articletitled, Abstract 920: Harnessing multiple mechanisms of action to target Nectin-4 as anti-tumor therapeutics
Journal Articles

Abstract 1869: Novel TNFR2 antibodies to overcome T cell exhaustion and suppressive tumor microenvironment

Chi Shing Sum, Makenzie Danton, Qii hu, Alla Pritsker, Ray Lin, Raymond Yu, Kevin Chen, Fangqiang Tang, Thomas Pohl, Samantha Wallner, Ahmed Hassan, Huarui Lu, Haichun Huang, James Pei, Zhong Liu, Han Li, Ming Lei
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1869.
https://doi.org/10.1158/1538-7445.AM2021-1869
Published: 01 July 2021
View articletitled, Abstract 1869: Novel TNFR2 antibodies to overcome T cell exhaustion and suppressive tumor microenvironment
Journal Articles

Vaccination with Tumor Cells Engineered to Secrete Interleukin 2-Immunoglobulin G Fusion Protein Induces Tumor Rejection

Silvia Bulfone-Paus, Horst von Bernuth, René Rückert, Joachim Wachtlin, Daniela Ungureanu, Michael Notter, Hans Krause, Thomas Pohl, Ralf Paus, Ulrich Kunzendorf
Journal: Cancer Research
Cancer Res (1998) 58 (13): 2707–2710.
Published: 01 July 1998
View articletitled, Vaccination with Tumor Cells Engineered to Secrete Interleukin 2-Immunoglobulin G Fusion Protein Induces Tumor Rejection
Open the PDF for Vaccination with Tumor Cells Engineered to Secrete Interleukin 2-Immunoglobulin G Fusion Protein Induces Tumor Rejection in another window